List of works - Matthias Bartenstein

ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts.

scientific article published on 26 November 2015

Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells.

scientific article published on 5 November 2018

Bone marrow fibrosis in primary myelofibrosis: pathogenic mechanisms and the role of TGF-β

scientific article

Efficacy of ALK5 inhibition in myelofibrosis.

scientific article published on 06 April 2017

Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/β-Catenin Activation

scientific article published on 6 July 2017

IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells

scientific article published on 25 March 2015

Inhibition of IL-32 activation by α-1 antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation model ⬇️

scientific article published on September 6, 2011

Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts

scientific article published on 01 November 2019

Misidentification of MLL3 and other mutations in cancer due to highly homologous genomic regions

scientific article published on 10 July 2019

Myelodysplastic Syndrome and Sweet's Syndrome Are Associated with a Mutation in Isocitrate Dehydrogenase 1

scientific article published on 01 April 2018

North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies

scientific article published on 13 August 2018

Pexmetinib: A Novel Dual Inhibitor of Tie2 and p38 MAPK with Efficacy in Preclinical Models of Myelodysplastic Syndromes and Acute Myeloid Leukemia.

scientific article published on 10 June 2016

Preparing for DSM 5 - assessment of personality pathology during psychoanalytic and psychiatric treatments

scientific article published on 26 April 2011

Reduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic syndromes.

scientific article

The RUNX1/IL-34/CSF-1R axis is an autocrinally regulated modulator of resistance to BRAF-V600E inhibition in melanoma

scientific article published on 26 July 2018

The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes

scientific article

List of works by Matthias Bartenstein

ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts.

Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells.

Bone marrow fibrosis in primary myelofibrosis: pathogenic mechanisms and the role of TGF-β

Efficacy of ALK5 inhibition in myelofibrosis.

Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/β-Catenin Activation

IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells

Inhibition of IL-32 activation by α-1 antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation model ⬇️

Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts

Misidentification of MLL3 and other mutations in cancer due to highly homologous genomic regions

Myelodysplastic Syndrome and Sweet's Syndrome Are Associated with a Mutation in Isocitrate Dehydrogenase 1

North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies

Pexmetinib: A Novel Dual Inhibitor of Tie2 and p38 MAPK with Efficacy in Preclinical Models of Myelodysplastic Syndromes and Acute Myeloid Leukemia.

Preparing for DSM 5 - assessment of personality pathology during psychoanalytic and psychiatric treatments

Reduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic syndromes.

The RUNX1/IL-34/CSF-1R axis is an autocrinally regulated modulator of resistance to BRAF-V600E inhibition in melanoma

The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes